1. Home
  2. HHS vs IRIX Comparison

HHS vs IRIX Comparison

Compare HHS & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$4.24

Market Cap

17.7M

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.71

Market Cap

15.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HHS
IRIX
Founded
1923
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
15.0M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
HHS
IRIX
Price
$4.24
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
280.1K
86.0K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
97.35
51.85
EPS
N/A
N/A
Revenue
$159,570,000.00
$41,593,000.00
Revenue This Year
N/A
$3.07
Revenue Next Year
N/A
$6.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.70
52 Week High
$4.50
$1.65

Technical Indicators

Market Signals
Indicator
HHS
IRIX
Relative Strength Index (RSI) 70.17 31.53
Support Level $2.70 $0.70
Resistance Level $4.50 $1.14
Average True Range (ATR) 0.28 0.04
MACD 0.01 0.00
Stochastic Oscillator 82.00 0.54

Price Performance

Historical Comparison
HHS
IRIX

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: